Suzhou Key Laboratory for Radiation Oncology, Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, China.
Gut Microbes. 2024 Jan-Dec;16(1):2347722. doi: 10.1080/19490976.2024.2347722. Epub 2024 May 5.
The intestine is prone to radiation damage in patients undergoing radiotherapy for pelvic tumors. However, there are currently no effective drugs available for the prevention or treatment of radiation-induced enteropathy (RIE). In this study, we aimed at investigating the impact of indole-3-carboxaldehyde (I3A) derived from the intestinal microbiota on RIE. Intestinal organoids were isolated and cultivated for screening radioprotective tryptophan metabolites. A RIE model was established using 13 Gy whole-abdominal irradiation in male C57BL/6J mice. After oral administration of I3A, its radioprotective ability was assessed through the observation of survival rates, clinical scores, and pathological analysis. Intestinal stem cell survival and changes in the intestinal barrier were observed through immunofluorescence and immunohistochemistry. Subsequently, the radioprotective mechanisms of I3A was investigated through 16S rRNA and transcriptome sequencing, respectively. Finally, human colon cancer cells and organoids were cultured to assess the influence of I3A on tumor radiotherapy. I3A exhibited the most potent radioprotective effect on intestinal organoids. Oral administration of I3A treatment significantly increased the survival rate in irradiated mice, improved clinical and histological scores, mitigated mucosal damage, enhanced the proliferation and differentiation of Lgr5 intestinal stem cells, and maintained intestinal barrier integrity. Furthermore, I3A enhanced the abundance of probiotics, and activated the AhR/IL-10/Wnt signaling pathway to promote intestinal epithelial proliferation. As a crucial tryptophan metabolite, I3A promotes intestinal epithelial cell proliferation through the AhR/IL-10/Wnt signaling pathway and upregulates the abundance of probiotics to treat RIE. Microbiota-derived I3A demonstrates potential clinical application value for the treatment of RIE.
肠道在接受盆腔肿瘤放射治疗的患者中容易受到辐射损伤。然而,目前尚无有效的药物可用于预防或治疗放射性肠炎(RIE)。在这项研究中,我们旨在研究肠道微生物群衍生的吲哚-3-甲醛(I3A)对 RIE 的影响。分离并培养肠类器官,以筛选放射保护色氨酸代谢物。使用 13Gy 全腹部照射在雄性 C57BL/6J 小鼠中建立 RIE 模型。在口服 I3A 后,通过观察存活率、临床评分和病理分析来评估其放射保护能力。通过免疫荧光和免疫组织化学观察肠干细胞的存活和肠屏障的变化。随后,通过 16S rRNA 和转录组测序分别研究了 I3A 的放射保护机制。最后,培养人结肠癌细胞和类器官,以评估 I3A 对肿瘤放疗的影响。I3A 对肠类器官表现出最强的放射保护作用。口服 I3A 治疗可显著提高照射小鼠的存活率,改善临床和组织学评分,减轻黏膜损伤,增强 Lgr5 肠干细胞的增殖和分化,并维持肠屏障完整性。此外,I3A 增加了益生菌的丰度,激活了 AhR/IL-10/Wnt 信号通路,促进了肠上皮细胞的增殖。作为一种重要的色氨酸代谢物,I3A 通过 AhR/IL-10/Wnt 信号通路促进肠上皮细胞增殖,并上调益生菌的丰度,从而治疗 RIE。肠道微生物群衍生的 I3A 具有治疗 RIE 的潜在临床应用价值。